There are currently 81 active clinical trials seeking participants for Diabetes research studies. The states with the highest number of trials for Diabetes participants are California, Texas, Florida and Pennsylvania.
The Mount Sinai Diabetic Foot Ulcer Prospective Trial
NCT03404895
Recruiting
The purpose of this study is to evaluate whether placing stent(s) for a blockage in a leg vein will help improve the healing of diabetic foot ulcers (DFU). The investigators know from having taken care of many patients with diabetic foot ulcers that it is a major cause of disability and amputation. These diabetic foot ulcers frequently heal slowly or not at all. They sometimes become infected and require antibiotic therapy, debridement and amputation. The investigators normally take care of a di... Read More
Gender:
All
Ages:
Between 30 years and 64 years
Trial Updated:
11/14/2023
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Diabetes, Diabetic Foot Ulcer, Edema
Register for Updates
Personalized Responses to Dietary Composition Trial 3
NCT04735835
Recruiting
The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and controlled dietary intervention, for the purpose of testing postprandial responses to specific mixed meals, in addition to a free-living period with a dietary record for measuring responses to a large v... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
07/28/2023
Locations: Zoe US Inc., Needham, Massachusetts +1 locations
Conditions: Diabetes, Heart Diseases, Diet Habit, Diet Modification, Healthy, Obesity, Metabolism, Microbial Colonization
Register for Updates
The T1D Exchange Registry
NCT04629586
Recruiting
The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes. To participate, you will be asked to: Read and sign an online informed consent form Take a survey describing specific demog... Read More
Gender:
All
Ages:
All
Trial Updated:
05/04/2023
Locations: T1D Exchange, Boston, Massachusetts
Conditions: Diabetes Mellitus, Type 1, Diabetes, Type 1 Diabetes, Diabetes Mellitus
Register for Updates
Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
NCT05593653
Recruiting
The aim of this study is to determine if suvorexant can help treat the severity of insomnia in midlife women who are pre-diabetic.
Gender:
Female
Ages:
Between 40 years and 65 years
Trial Updated:
02/16/2023
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Insomnia, Diabetes, Menopause
Register for Updates
Uric Acid Lowering Trial in Youth Onset T2D
NCT03899883
Recruiting
Adolescents and young adults with youth-onset type 2 diabetes (T2D) are disproportionally impacted by hyperuricemia compared to non-diabetic peers and youth with type 1 diabetes (T1D). In fact, 50% of males with youth-onset T2D have serum uric acid (SUA) greater than 6.8 mg/dl. The investigators also recently demonstrated that higher SUA conferred greater odds of developing hypertension and diabetic kidney disease (DKD) in youth with T2D over 7 years follow-up. Elevated SUA is thought to lead to... Read More
Gender:
Male
Ages:
Between 18 years and 25 years
Trial Updated:
02/07/2023
Locations: Children's Hospital Colorado, Aurora, Colorado
Conditions: Diabetic Kidney Disease, Hyperuricemia, Diabetes, Diabetes Mellitus, Type 2, Type2 Diabetes, Type 2 Diabetes Mellitus, Diabetic Nephropathies, Diabetes Complications
Register for Updates
Clinical Investigation of K'Watch - Lab & Home Study
NCT05093569
Recruiting
This study categorized as a non significant risk trial is a monocentric, prospective, open-label comparative, paired-design trial aims to evaluate the performance and the tolerance of K'Watch CGM system in comparison with conventional reference (YSI system, BGM system and CGM systems ) . This trial will be conducted on patients with Type 1 and 2 of diabetes for 8 days.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
04/25/2022
Locations: AMCR Institute, San Diego, California
Conditions: Diabetes
Register for Updates
Imaging Histone Deacetylase in the Heart
NCT03549559
Recruiting
The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with diabetes, and healthy volunteers.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
03/01/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis, Diabetes
Register for Updates
Continuous Monitoring and Control of Hypoglycemia
NCT03340831
Recruiting
Evaluate safety of non-adjunctive CGM use in CGM naive participants.
Gender:
All
Ages:
2 years and above
Trial Updated:
09/17/2021
Locations: Scripps Whittier Diabetes Institute, La Jolla, California +24 locations
Conditions: Diabetes
Register for Updates
Glucose Differences Between the Left Arm and Right Arm in Diabetic Patients Using a Continuous Glucose Monitor
NCT04790760
Recruiting
Continuous glucose monitoring (CGM) is an emerging field for diabetes management. CGMs are small devices primarily placed on a patient's upper arm that allow providers and patients to individualize therapy by looking at real time glucose levels. While the accuracy of these devices is extensively researched, there are no large-scale studies evaluating the differences between left and right arm glucose readings in the diabetic population. Additionally cinnamon and aloe vera are supplements commonl... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/05/2021
Locations: Manshadi Heart Institute, Inc., Stockton, California
Conditions: Diabetes
Register for Updates